Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2012 Dec 14;20(5):10.1080/13825585.2012.747671. doi: 10.1080/13825585.2012.747671

Table 2.

Characteristics of the Co-STAR population at first Co-STAR visit

Characteristic Tamoxifen Raloxifene All population
Mean SD Mean SD Mean SD p-value*
Time between (months)
Age 28.48 18.43 27.02 18.55 27.74 18.50 0.13
67.21 4.36 67.01 4.30 67.11 4.33 0.39
N % N % N % p-value*
Race
 Other 40 5.50 38 5.05 78 5.27 0.70
 White 687 94.50 714 94.95 1401 94.73
Education
 < High School 34 4.68 40 5.32 74 5.00 0.57
 ≥ High School 693 95.32 712 94.68 1405 95.00
*

Note: T-test is used to test for difference between treatment groups for characteristics measured on continuous scale and chi-square test for categorical covariates.